Kercheville Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,205
| Closed | -$422K | – | 113 |
|
|
2025
Q1 | $422K | Sell |
5,205
-7,770
| -60% | -$630K | 0.17% | 63 |
|
|
2024
Q4 | $1.17M | Sell |
12,975
-2,750
| -17% | -$248K | 0.45% | 43 |
|
|
2024
Q3 | $1.55M | Buy |
15,725
+6,045
| +62% | +$597K | 0.66% | 35 |
|
|
2024
Q2 | $897K | Buy |
9,680
+75
| +0.8% | +$6.95K | 0.39% | 43 |
|
|
2024
Q1 | $911K | Buy |
+9,605
| New | +$911K | 0.43% | 41 |
|
|
2023
Q3 | – | Sell |
-2,600
| Closed | -$216K | – | 78 |
|
|
2023
Q2 | $216K | Buy |
+2,600
| New | +$216K | 0.13% | 65 |
|